These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30044337)

  • 1. Impact of Significant Decreases Over Time in the Proportion of Sexually Active Medicaid Women Who Had Papanicolaou Testing or Were Pregnant on Trends of Overall Chlamydia Testing Rates.
    Tao G; Kreisel K; Gift TL
    Sex Transm Dis; 2018 Nov; 45(11):e90-e93. PubMed ID: 30044337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of the American College of Obstetricians and Gynecologists Guideline Changes in Pap Tests on Annual Chlamydia Test Rates.
    Hsieh HL; Huppert J; Patel CG; Tao G
    J Adolesc Health; 2017 Oct; 61(4):440-445. PubMed ID: 28754585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial Differences in Receipt of Chlamydia Testing Among Medicaid-Insured Women in 2013.
    Patel CG; Chesson HW; Tao G
    Sex Transm Dis; 2016 Mar; 43(3):147-51. PubMed ID: 26859801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Chlamydia Screening Rate in Young Sexually Active Women Using HEDIS Measures in the United States, 2011 to 2020.
    He L; Patel C; Tao G
    Sex Transm Dis; 2023 Jul; 50(7):415-419. PubMed ID: 36943794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding sexual activity and Chlamydia testing rate based on linked national survey and Medicaid claims data.
    Tao G; Hua J; Chen JL
    PLoS One; 2015; 10(4):e0122927. PubMed ID: 25875858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia screening of young sexually active, Medicaid-insured women by race and ethnicity, 2002-2005.
    Christiansen-Lindquist L; Tao G; Hoover K; Frank R; Kent C
    Sex Transm Dis; 2009 Oct; 36(10):642-6. PubMed ID: 19652631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for chlamydia in adolescents and young women.
    Mangione-Smith R; McGlynn EA; Hiatt L
    Arch Pediatr Adolesc Med; 2000 Nov; 154(11):1108-13. PubMed ID: 11074851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia screening among sexually active young female enrollees of health plans--United States, 2000-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(14):362-5. PubMed ID: 19373196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State Variation in Enrollment Gap, Sexual Activity, and Chlamydia Testing Rate Among Young Medicaid Women.
    Tao G; Patel CG
    Sex Transm Dis; 2016 Oct; 43(10):595-8. PubMed ID: 27626186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific chlamydial infection among pregnant women in the United States: evidence for updated recommendations.
    Tao G; Hoover KW; Nye MB; Body BA
    Sex Transm Dis; 2014 Sep; 41(9):556-9. PubMed ID: 25118971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Changes in Cervical Cancer Screening Guidelines on Chlamydia Testing.
    Naimer MS; Kwong JC; Bhatia D; Moineddin R; Whelan M; Campitelli MA; Macdonald L; Lofters A; Tuite A; Bogler T; Permaul JA; McIsaac WJ
    Ann Fam Med; 2017 Jul; 15(4):329-334. PubMed ID: 28694268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Significant Impact of Different Insurance Enrollment Criteria on the HEDIS Chlamydia Screening Measure for Young Women Enrolled in Medicaid and Commercial Insurance Plans.
    Patel CG; Tao G
    Sex Transm Dis; 2015 Oct; 42(10):575-9. PubMed ID: 26372930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia screening among sexually active young female enrollees of health plans--United States, 1999-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Oct; 53(42):983-5. PubMed ID: 15514579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia testing patterns for commercially insured women, 2008.
    Tao G; Hoover KW; Kent CK
    Am J Prev Med; 2012 Apr; 42(4):337-41. PubMed ID: 22424245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant difference in HEDIS annual chlamydia testing rates between women who had given birth and those who had not among young Medicaid women.
    Tao G; Owusu-Edusei K; Friedman E; Aslam M; Viall AH; Dietz P; Gift TL
    Sex Health; 2018 Jul; 15(4):374-375. PubMed ID: 29860971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Medicaid managed care interventions in Chlamydia screening by physicians.
    Pourat N; Kominski GF; Nihalani J; Neiman R; Bolan G
    Sex Transm Dis; 2011 Apr; 38(4):286-92. PubMed ID: 21233791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of chlamydia and Pap-smear abnormalities in pregnant adolescents warrants routine screening.
    Quinlivan JA; Petersen RW; Gurrin LC
    Aust N Z J Obstet Gynaecol; 1998 Aug; 38(3):254-7. PubMed ID: 9761147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efforts by commercial health plans to increase Chlamydia trachomatis screening among their members.
    Atherly A; Blake SC
    Sex Transm Dis; 2013 Jan; 40(1):55-60. PubMed ID: 23254117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Cervical Cancer Screening Guidelines on Screening for Chlamydia.
    Ursu A; Sen A; Ruffin M
    Ann Fam Med; 2015; 13(4):361-3. PubMed ID: 26195682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A paradox: overscreening of older women for Chlamydia while too few younger women are being tested.
    Berman SM; Satterwhite CL
    Sex Transm Dis; 2011 Feb; 38(2):130-2. PubMed ID: 21173722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.